Peptide Guides — Mechanism, Research & Handling

GLP-1 + glucagon dual agonist derived from oxyntomodulin.

Combined GHRH analogue + selective ghrelin-receptor secretagogue.

Highly selective ghrelin-receptor GH secretagogue.

Stabilised GHRH analogue with the most clinical data in its class.

Mitochondrial-derived peptide studied in AMPK and metabolic signalling.

Cell-permeable tetrapeptide that targets the inner mitochondrial membrane.

Copper-binding tripeptide studied in skin and matrix remodelling research.

Melanocortin receptor agonist derived from the Melanotan 2 scaffold.

Adamantane-modified nootropic peptide related to the Semax family.

Spadin-derived peptide studied as a TREK-1 potassium channel blocker.

Long-acting amylin analogue studied alongside GLP-1 compounds.

C-terminal growth hormone fragment studied for lipid metabolism.

Selective alpha-MSH analogue acting mainly at MC1R.

Central redox coenzyme studied in cellular energy and repair research.

Synthetic tuftsin analogue studied in anxiolytic and BDNF research.

Stabilised ACTH fragment studied in cognitive and neuroprotection models.

C-terminal alpha-MSH tripeptide studied in inflammation models.

Four-residue pineal peptide studied in telomerase research.

Triple GLP-1/GIP/glucagon agonist — mechanism, trial data and UK legal status.

Dual GIP/GLP-1 agonist — research background, handling and concentrations.

GLP-1 receptor agonist — mechanism, published research and reconstitution.

Melanocortin agonist — research context and handling.

GHRH analogue studied alongside GH secretagogues such as Ipamorelin.

Pentadecapeptide from gastric juice, studied in tissue repair models.

Synthetic fragment of Thymosin Beta-4 studied in cell migration.